Literature DB >> 11024546

Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes.

S N Noe1, C Newton, R Widen, H Friedman, T W Klein.   

Abstract

The expression and function of cannabinoid receptor 1 (CB1) in mouse immune cells is unclear. Here we show that splenic B cells express more CB1 mRNA than T cells. Furthermore, splenocytes stimulated with the T cell mitogens, PMA/Io and anti-CD3, showed a decrease in CB1 message while cultures stimulated with the B cell mitogen, anti-CD40 antibody, showed an increase in message. In addition, co-treatment with mitogens and IL-2 uniformly caused an increase in CB1 mRNA. It is suggested that signaling pathways activated by T cell mitogens lead to decreased CB1 gene activation while pathways activated by B cell mitogens and IL-2 lead to increased CB1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024546     DOI: 10.1016/s0165-5728(00)00349-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.

Authors:  Patricia A Fair; Erin Driscoll; Meagan A M Mollenhauer; Sarah G Bradshaw; Se Hun Yun; Kurunthachalam Kannan; Gregory D Bossart; Deborah E Keil; Margie M Peden-Adams
Journal:  J Immunotoxicol       Date:  2011-01-24       Impact factor: 3.000

2.  Functional expression of the P2Y14 receptor in murine T-lymphocytes.

Authors:  Michelle Scrivens; John M Dickenson
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.

Authors:  Catherine A Newton; Ping-Jen Chou; Izabella Perkins; Thomas W Klein
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-16       Impact factor: 4.147

4.  Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212.

Authors:  J Ludovic Croxford; Stephen D Miller
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 5.  Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.

Authors:  Kathleen L McCoy
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

6.  RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling.

Authors:  Laura B Kuhn; Stefanie Valentin; Kristina Stojanovic; Daniel C Strobl; Tea Babushku; Yan Wang; Ursula Rambold; Laura Scheffler; Sonja Grath; Dorothy John-Robbert; Helmut Blum; Annette Feuchtinger; Andreas Blutke; Falk Weih; Daisuke Kitamura; Roland Rad; Lothar J Strobl; Ursula Zimber-Strobl
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

Review 7.  The Interplay between the Immune and the Endocannabinoid Systems in Cancer.

Authors:  Mariantonia Braile; Simone Marcella; Gianni Marone; Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.